Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
DWHP Announces Extension of The Expiration Time of Its Tender Offer 2021-01-22 12:34
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19 2021-01-22 12:00
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) 2021-01-22 02:25
AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site 2021-01-22 02:00
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance 2021-01-22 01:59
Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021 2021-01-21 22:00
China Jo-Jo Drugstores Hosts the First Suppliers Conference in China 2021-01-21 21:30
Envirotainer Opens First RAP e2 Station in Taipei 2021-01-21 16:14
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021 2021-01-21 16:00
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area 2021-01-21 12:35
Seegene to advance business in Latin America in the New Year 2021-01-21 07:56
ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage 2021-01-21 06:00
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study 2021-01-20 23:35
Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content 2021-01-20 16:15
Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002 2021-01-20 13:53
Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China 2021-01-20 10:39
Ortho Clinical Diagnostics Announces Launch of Initial Public Offering 2021-01-19 21:57
Medibio Granted CE Mark Approval for MEBsleep 2021-01-19 21:06
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care 2021-01-19 20:08
Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL 2021-01-19 19:30
1 633 634 635 636 637 1097